首页> 外文OA文献 >Reporting of quality attributes in scientific publications presenting biosimilarity assessments of (intended) biosimilars: a systematic literature review

【2h】

Reporting of quality attributes in scientific publications presenting biosimilarity assessments of (intended) biosimilars: a systematic literature review

机译：提出科学出版物质量属性（预期的）生物仿制性的生物偏换评估：系统文献综述

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Ali M. Alsamil; Thijs J. Giezen; Toine C. Egberts; Hubert G. Leufkens; Arnold G. Vulto; Martijn R. van der Plas; Helga Gardarsdottir;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Comparison of consistency and complementarity of reporting biosimilar quality attributes between regulatory and scientific communities: An adalimumab case study [J] . Alsamil Ali M., Giezen Thijs J., Egberts Toine C., Biologicals: Journal of the International Association of Biological Standardization . 2021,第1期

机译：报告和科学社区之间报告生物仿优质属性的一致性和互补性的比较：AdalimalAB案例研究
2. Is the decision on the use of biosimilar growth hormone based on high quality scientific evidence? - A systematic review [J] . FryklundL., RitzénM., BertilssonG., European journal of clinical pharmacology . 2014,第5期

机译：是否基于高质量的科学证据决定使用生物仿制药的生长激素？ -系统审查
3. SYSTEMATIC LITERATURE REVIEW AND ASSESSMENT OF THE REPORTING QUALITY OF ECONOMIC EVALUATION STUDIES IN NON-SMALL CELL LUNG CANCER IN CHINA [J] . Zhou J., Ma F., Cheng X., Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2016,第7期

机译：中国非小细胞肺癌经济评价研究报告质量的系统性文献综述与评价
4. DEEP BIOSIMILARITY ASSESSMENT BY MONITORING MULTIPLE CRITICAL QUALITY ATTRIBUTES OF AN INTACT MONOCLONAL ANTIBODY DRUG USING NATIVE IEC AND SEC COUPLED TO NATIVE ORBITRAP MS [C] . Aaron Bailey, Terry Zhang, Stephane Houel, International Mass Spectrometry Conference . 2018

机译：通过使用天然IEC和秒连接到天然横壁架MS的天然IEC和SEC来监测完整单克隆抗体药物的多重关键质量属性的深度生物脂序评估
5. Facilitators and Barriers to Biosimilar Adoption: a Systematic Review of the Global Stakeholder Perspective [D] . Nair, Sonam. 2020

机译：促进者和生物仿制剂的障碍：对全球利益攸关方认为的系统审查
6. Type and Extent of Information on (Potentially Critical) Quality Attributes Described in European Public Assessment Reports for Adalimumab Biosimilars [O] . Ali M. Alsamil, Thijs J. Giezen, Toine C. Egberts, 2021

机译：欧洲公共评估中描述的（潜在批判性）质量属性的信息的类型和范围用于Adalimalab BioSimilars
7. Adalimumab Biosimilars in the Treatment of Rheumatoid Arthritis: A Systematic Review of the Evidence for Biosimilarity [O] . Tom W. J. Huizinga, Yoshifumi Torii, Rafael Muniz 2020

机译：atabalimalab生物纤米治疗类风湿性关节炎：对生物脂序证据的系统审查

Reporting of quality attributes in scientific publications presenting biosimilarity assessments of (intended) biosimilars: a systematic literature review

著录项

引文网络

相似文献

相关主题

期刊订阅